IBDEI0DC ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13337,1,4,0)
 ;;=4^F16.14
 ;;^UTILITY(U,$J,358.3,13337,2)
 ;;=^5003328
 ;;^UTILITY(U,$J,358.3,13338,0)
 ;;=F16.24^^58^697^5
 ;;^UTILITY(U,$J,358.3,13338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13338,1,3,0)
 ;;=3^Hallucinogen Induced Bipolar Disorder w/ Mod/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,13338,1,4,0)
 ;;=4^F16.24
 ;;^UTILITY(U,$J,358.3,13338,2)
 ;;=^5003341
 ;;^UTILITY(U,$J,358.3,13339,0)
 ;;=F16.94^^58^697^6
 ;;^UTILITY(U,$J,358.3,13339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13339,1,3,0)
 ;;=3^Hallucinogen Induced Bipolar Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,13339,1,4,0)
 ;;=4^F16.94
 ;;^UTILITY(U,$J,358.3,13339,2)
 ;;=^5003353
 ;;^UTILITY(U,$J,358.3,13340,0)
 ;;=F16.159^^58^697^7
 ;;^UTILITY(U,$J,358.3,13340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13340,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,13340,1,4,0)
 ;;=4^F16.159
 ;;^UTILITY(U,$J,358.3,13340,2)
 ;;=^5003331
 ;;^UTILITY(U,$J,358.3,13341,0)
 ;;=F16.259^^58^697^8
 ;;^UTILITY(U,$J,358.3,13341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13341,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic Disorder w/ Mod/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,13341,1,4,0)
 ;;=4^F16.259
 ;;^UTILITY(U,$J,358.3,13341,2)
 ;;=^5003344
 ;;^UTILITY(U,$J,358.3,13342,0)
 ;;=F16.959^^58^697^9
 ;;^UTILITY(U,$J,358.3,13342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13342,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,13342,1,4,0)
 ;;=4^F16.959
 ;;^UTILITY(U,$J,358.3,13342,2)
 ;;=^5003356
 ;;^UTILITY(U,$J,358.3,13343,0)
 ;;=F16.99^^58^697^38
 ;;^UTILITY(U,$J,358.3,13343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13343,1,3,0)
 ;;=3^Phencyclidine Use Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,13343,1,4,0)
 ;;=4^F16.99
 ;;^UTILITY(U,$J,358.3,13343,2)
 ;;=^5133359
 ;;^UTILITY(U,$J,358.3,13344,0)
 ;;=F16.983^^58^697^16
 ;;^UTILITY(U,$J,358.3,13344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13344,1,3,0)
 ;;=3^Hallucinogen Persisting Perception Disorder
 ;;^UTILITY(U,$J,358.3,13344,1,4,0)
 ;;=4^F16.983
 ;;^UTILITY(U,$J,358.3,13344,2)
 ;;=^5003358
 ;;^UTILITY(U,$J,358.3,13345,0)
 ;;=F16.20^^58^697^37
 ;;^UTILITY(U,$J,358.3,13345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13345,1,3,0)
 ;;=3^Phencyclidine Use Disorder,Severe
 ;;^UTILITY(U,$J,358.3,13345,1,4,0)
 ;;=4^F16.20
 ;;^UTILITY(U,$J,358.3,13345,2)
 ;;=^5003336
 ;;^UTILITY(U,$J,358.3,13346,0)
 ;;=F16.180^^58^697^17
 ;;^UTILITY(U,$J,358.3,13346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13346,1,3,0)
 ;;=3^Phencyclidine Induced Anxiety Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,13346,1,4,0)
 ;;=4^F16.180
 ;;^UTILITY(U,$J,358.3,13346,2)
 ;;=^5003332
 ;;^UTILITY(U,$J,358.3,13347,0)
 ;;=F16.280^^58^697^18
 ;;^UTILITY(U,$J,358.3,13347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13347,1,3,0)
 ;;=3^Phencyclidine Induced Anxiety Disorder w/ Moderate/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,13347,1,4,0)
 ;;=4^F16.280
 ;;^UTILITY(U,$J,358.3,13347,2)
 ;;=^5003345
 ;;^UTILITY(U,$J,358.3,13348,0)
 ;;=F16.980^^58^697^19
 ;;^UTILITY(U,$J,358.3,13348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13348,1,3,0)
 ;;=3^Phencyclidine Induced Anxiety Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,13348,1,4,0)
 ;;=4^F16.980
 ;;^UTILITY(U,$J,358.3,13348,2)
 ;;=^5003357
 ;;^UTILITY(U,$J,358.3,13349,0)
 ;;=F16.14^^58^697^20
 ;;^UTILITY(U,$J,358.3,13349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13349,1,3,0)
 ;;=3^Phencyclidine Induced Bipolar & Related Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,13349,1,4,0)
 ;;=4^F16.14
 ;;^UTILITY(U,$J,358.3,13349,2)
 ;;=^5003328
 ;;^UTILITY(U,$J,358.3,13350,0)
 ;;=F16.24^^58^697^21
 ;;^UTILITY(U,$J,358.3,13350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13350,1,3,0)
 ;;=3^Phencyclidine Induced Bipolar & Related Disorder w/ Moderate/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,13350,1,4,0)
 ;;=4^F16.24
 ;;^UTILITY(U,$J,358.3,13350,2)
 ;;=^5003341
 ;;^UTILITY(U,$J,358.3,13351,0)
 ;;=F16.94^^58^697^22
 ;;^UTILITY(U,$J,358.3,13351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13351,1,3,0)
 ;;=3^Phencyclidine Induced Bipolar & Related Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,13351,1,4,0)
 ;;=4^F16.94
 ;;^UTILITY(U,$J,358.3,13351,2)
 ;;=^5003353
 ;;^UTILITY(U,$J,358.3,13352,0)
 ;;=F16.14^^58^697^23
 ;;^UTILITY(U,$J,358.3,13352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13352,1,3,0)
 ;;=3^Phencyclidine Induced Depressive Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,13352,1,4,0)
 ;;=4^F16.14
 ;;^UTILITY(U,$J,358.3,13352,2)
 ;;=^5003328
 ;;^UTILITY(U,$J,358.3,13353,0)
 ;;=F16.24^^58^697^24
 ;;^UTILITY(U,$J,358.3,13353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13353,1,3,0)
 ;;=3^Phencyclidine Induced Depressive Disorder w/ Moderate/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,13353,1,4,0)
 ;;=4^F16.24
 ;;^UTILITY(U,$J,358.3,13353,2)
 ;;=^5003341
 ;;^UTILITY(U,$J,358.3,13354,0)
 ;;=F16.94^^58^697^25
 ;;^UTILITY(U,$J,358.3,13354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13354,1,3,0)
 ;;=3^Phencyclidine Induced Depressive Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,13354,1,4,0)
 ;;=4^F16.94
 ;;^UTILITY(U,$J,358.3,13354,2)
 ;;=^5003353
 ;;^UTILITY(U,$J,358.3,13355,0)
 ;;=F16.159^^58^697^26
 ;;^UTILITY(U,$J,358.3,13355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13355,1,3,0)
 ;;=3^Phencyclidine Induced Psychotic Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,13355,1,4,0)
 ;;=4^F16.159
 ;;^UTILITY(U,$J,358.3,13355,2)
 ;;=^5003331
 ;;^UTILITY(U,$J,358.3,13356,0)
 ;;=F16.259^^58^697^27
 ;;^UTILITY(U,$J,358.3,13356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13356,1,3,0)
 ;;=3^Phencyclidine Induced Psychotic Disorder w/ Moderate/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,13356,1,4,0)
 ;;=4^F16.259
 ;;^UTILITY(U,$J,358.3,13356,2)
 ;;=^5003344
 ;;^UTILITY(U,$J,358.3,13357,0)
 ;;=F16.959^^58^697^28
 ;;^UTILITY(U,$J,358.3,13357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13357,1,3,0)
 ;;=3^Phencyclidine Induced Psychotic Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,13357,1,4,0)
 ;;=4^F16.959
 ;;^UTILITY(U,$J,358.3,13357,2)
 ;;=^5003356
 ;;^UTILITY(U,$J,358.3,13358,0)
 ;;=F16.129^^58^697^32
 ;;^UTILITY(U,$J,358.3,13358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13358,1,3,0)
 ;;=3^Phencyclidine Intoxication w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,13358,1,4,0)
 ;;=4^F16.129
 ;;^UTILITY(U,$J,358.3,13358,2)
 ;;=^5003327
 ;;^UTILITY(U,$J,358.3,13359,0)
 ;;=F16.229^^58^697^33
 ;;^UTILITY(U,$J,358.3,13359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13359,1,3,0)
 ;;=3^Phencyclidine Intoxication w/ Moderate/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,13359,1,4,0)
 ;;=4^F16.229
 ;;^UTILITY(U,$J,358.3,13359,2)
 ;;=^5003340
 ;;^UTILITY(U,$J,358.3,13360,0)
 ;;=F16.929^^58^697^34
 ;;^UTILITY(U,$J,358.3,13360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13360,1,3,0)
 ;;=3^Phencyclidine Intoxication w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,13360,1,4,0)
 ;;=4^F16.929
 ;;^UTILITY(U,$J,358.3,13360,2)
 ;;=^5003352
 ;;^UTILITY(U,$J,358.3,13361,0)
 ;;=F16.121^^58^697^29
 ;;^UTILITY(U,$J,358.3,13361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13361,1,3,0)
 ;;=3^Phencyclidine Intoxication Delirium w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,13361,1,4,0)
 ;;=4^F16.121
 ;;^UTILITY(U,$J,358.3,13361,2)
 ;;=^5003325
 ;;^UTILITY(U,$J,358.3,13362,0)
 ;;=F16.221^^58^697^30
 ;;^UTILITY(U,$J,358.3,13362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13362,1,3,0)
 ;;=3^Phencyclidine Intoxication Delirium w/ Moderate/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,13362,1,4,0)
 ;;=4^F16.221
 ;;^UTILITY(U,$J,358.3,13362,2)
 ;;=^5003339
 ;;^UTILITY(U,$J,358.3,13363,0)
 ;;=F16.921^^58^697^31
